A systematic review and meta-analysis of the relative safety and efficacy of treating lower extremity deep vein thrombosis via pharmacomechanical thrombectomy and catheter-directed thrombolysis

被引:0
|
作者
Tian, Zhong [1 ,2 ]
Han, Hao [1 ]
Tian, Zhilong [1 ,2 ]
Sun, Pengcheng [1 ,2 ]
Qin, Ruihao [1 ,2 ]
Yuan, Fukang [1 ,2 ,3 ]
机构
[1] Xuzhou Med Univ, Xuzhou Clin Coll, Xuzhou, Peoples R China
[2] Xuzhou Cent Hosp, Dept Vasc Surg, South Road 19, Xuzhou 221009, Peoples R China
[3] Jiangsu Normal Univ, Sch Life Sci, Key Lab Biotechnol Med Plants Jiangsu Prov, Xuzhou, Peoples R China
关键词
Deep venous thrombosis of the lower extremities; AngioJet mechanical thrombectomy; catheter-directed thrombolysis; pharmacomechanical thrombectomy; meta-analysis; PERCUTANEOUS MECHANICAL THROMBECTOMY; POSTTHROMBOTIC SYNDROME;
D O I
10.1177/17085381241274556
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: To evaluate the safety and efficacy of pharmacomechanical thrombectomy and catheter-directed thrombolysis (CDT) as approaches to treating deep venous thrombosis of lower extremities (LEDVT). Methods: The PubMed, Web of Science, Wanfang, Embase, Chinese Science and Technology Journal, Cochrane, and China National Knowledge Infrastructure (CNKI) databases were systematically searched for relevant articles published through October 2023, after which appropriate inclusion and exclusion criteria were used to screen out relevant articles. Review Manager 5.4.1 was used to extract key data from these studies, and pooled analyses were conducted based on mead difference (MD) or odds ratio (OR) values and corresponding 95% confidence interval (CI). Study quality was assessed with the Newcastle-Ottawa scale. Trial registration: This study has been registered at INPLASY.COM (No. INPLASY2023100075). Results: In total, 31 relevant studies enrolling 2413 patients were included in this meta-analysis, with 1184 and 1229 patients in the AngioJet and CDT groups, respectively. These analyses revealed that the AngioJet group exhibited significantly higher rates of early postoperative deep vein patency (MD = 7.73, 95% CI (3.29, 12.17), p = .0006) and affected limb symptom improvement (MD = 6.31, 95% CI (1.82,10.80), p = .006) relative to the CDT group, whereas no differences in grade II or III thrombus clearance rates (OR = 1.30, 95% CI (0.95, 1.77), p = .10) or changes in thigh circumference before and after treatment (MD = 0.01, 95% CI (-0.80, 0.83), p = .97) were observed. The AngioJet group also exhibited lower urokinase doses (MD = -145.33, 95% CI (-164.28,126.38), p < .00001), shorter thrombolysis time (MD = -2.35, 95% CI(-2.80, -1.90), p < .00001), a less prolonged hospital stay (MD = -3.13, 95% CI(-3.81, -2.45), p < .00001), lower rates of PTS incidence (OR = 0.56, 95% CI(0.36, 0.88), p = .01), and reduced complication rates (OR = 0.51, 95% CI(0.31, 0.83), p = .0007). Conclusion: Studies published to date suggest that relative to CDT treatment, pharmacomechanical thrombectomy is associated with improved thrombus clearance, fewer complications, and lower complication rates in LEDVT patients, underscoring the safety and efficacy of this therapeutic strategy.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Safety of catheter-directed thrombolysis for the treatment of acute lower extremity deep vein thrombosis A systematic review and meta-analysis
    Wang, Li
    Zhang, Chuanlin
    Mu, Shaoyu
    Yeh, Chao Hsing
    Chen, Liqun
    Zhang, Zeju
    Wang, Xueqin
    MEDICINE, 2017, 96 (35)
  • [2] Pharmacomechanical Thrombectomy Versus Catheter-Directed Thrombolysis for Iliofemoral Deep Vein Thrombosis: A Meta-Analysis of Clinical Trials
    Tang, Tao
    Chen, Linyi
    Chen, Jinhui
    Mei, Tong
    Lu, Yongming
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [3] AngioJet Thrombectomy Versus Catheter-Directed Thrombolysis for Lower Extremity Deep Vein Thrombosis: A Meta-Analysis of Clinical Trials
    Li, Guan Qiang
    Wang, Lei
    Zhang, Xi Cheng
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2021, 27
  • [4] Catheter-directed thrombolysis for patients with acute lower extremity deep vein thrombosis: a meta-analysis
    Wang Li
    Zhang Chuanlin
    Mu Shaoyu
    Chao Hsing Yeh
    Chen Liqun
    Zhang Zeju
    REVISTA LATINO-AMERICANA DE ENFERMAGEM, 2018, 26
  • [5] Catheter-Directed Thrombolysis with Conventional Aspiration Thrombectomy for Lower Extremity Deep Vein Thrombosis
    Jeon, Yong Sun
    Yoon, Yong Han
    Cho, Joung Ym
    Baek, Wan Ki
    Kim, Kwang Ho
    Hong, Kee Chun
    Kim, Joung Taek
    YONSEI MEDICAL JOURNAL, 2010, 51 (02) : 197 - 201
  • [6] Safety and Efficacy of Aspiration Thrombectomy or Pharmacomechanical Thrombectomy after Catheter-Directed Thrombolysis for the Treatment of Acute Iliofemoral Deep Vein Thrombosis
    Lee, Joong Kwon
    Kim, Kyung Yun
    Byun, Seung Jae
    VASCULAR SPECIALIST INTERNATIONAL, 2020, 36 (03) : 144 - 150
  • [7] Catheter-directed pharmacomechanical thrombolysis for the management of deep vein thrombosis
    Klopotowski, Mariusz
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2011, 7 (04): : 311 - 316
  • [8] Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis
    Vedantham, S.
    Goldhaber, S. Z.
    Julian, J. A.
    Kahn, S. R.
    Jaff, M. R.
    Cohen, D. J.
    Magnuson, E.
    Razavi, M. K.
    Comerota, A. J.
    Gornik, H. L.
    Murphy, T. P.
    Lewis, L.
    Duncan, J. R.
    Nieters, P.
    Derfler, M. C.
    Filion, M.
    Gu, C. -S.
    Kee, S.
    Schneider, J.
    Saad, N.
    Blinder, M.
    Moll, S.
    Sacks, D.
    Lin, J.
    Rundback, J.
    Garcia, M.
    Razdan, R.
    VanderWoude, E.
    Marques, V.
    Kearon, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (23): : 2240 - 2252
  • [9] Catheter-directed thrombolysis vs pharmacomechanical catheter-directed thrombolysis in acute iliofemoral deep vein thrombosis
    Tawfik, Ahmad M.
    Zaidan, Mohamed H.
    Sorour, Waleed A.
    EGYPTIAN JOURNAL OF SURGERY, 2020, 39 (01): : 228 - 238
  • [10] Catheter-directed thrombolysis for symptomatic lower extremity deep vein thrombosis.
    Mewissen, MW
    Seabrook, GR
    Meissner, MH
    Haughton, SH
    BLOOD, 1998, 92 (10) : 501A - 501A